1837 rmb managers llc - direct investment history in Aspenbio pharma inc

Filed on 2007-07-19 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000022.txt Sec File: edgar/data/1363397/0001363399-07-000022-index.htm

2007-07-18 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 25140 shares at $5.43 remaining shares owned 2775271

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold by 1837 partners l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-19 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000022.txt Sec File: edgar/data/1363397/0001363399-07-000022-index.htm

2007-07-18 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 6330 shares at $5.43 remaining shares owned 2762911

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f4 these shares were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-19 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000022.txt Sec File: edgar/data/1363397/0001363399-07-000022-index.htm

2007-07-18 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 6030 shares at $5.43 remaining shares owned 2769241

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f3 these shares were sold from 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-18 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000021.txt Sec File: edgar/data/1363397/0001363399-07-000021-index.htm

2007-07-16 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 1680 shares at $5.33 remaining shares owned 2804783

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-18 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000021.txt Sec File: edgar/data/1363397/0001363399-07-000021-index.htm

2007-07-16 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 420 shares at $5.33 remaining shares owned 2803963

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f4 these shares were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-18 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000021.txt Sec File: edgar/data/1363397/0001363399-07-000021-index.htm

2007-07-16 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 400 shares at $5.33 remaining shares owned 2804383

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f3 these shares were sold from 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-18 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000021.txt Sec File: edgar/data/1363397/0001363399-07-000021-index.htm

2007-07-17 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 2382 shares at $5.33 remaining shares owned 2801581

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-18 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000021.txt Sec File: edgar/data/1363397/0001363399-07-000021-index.htm

2007-07-17 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 600 shares at $5.33 remaining shares owned 2800411

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f4 these shares were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-18 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000021.txt Sec File: edgar/data/1363397/0001363399-07-000021-index.htm

2007-07-17 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 570 shares at $5.33 remaining shares owned 2801011

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f3 these shares were sold from 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-12 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000020.txt Sec File: edgar/data/1363397/0001363399-07-000020-index.htm

2007-07-11 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 12792 shares at $4.66 remaining shares owned 2806463

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f3 these shares were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as the the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-12 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000020.txt Sec File: edgar/data/1363397/0001363399-07-000020-index.htm

2007-07-11 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 12408 shares at $4.67 remaining shares owned 2819255

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f3 these shares were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as the the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-12 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000020.txt Sec File: edgar/data/1363397/0001363399-07-000020-index.htm

2007-07-11 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 7208 shares at $4.66 remaining shares owned 2831663

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 parnters qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as the the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-12 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000020.txt Sec File: edgar/data/1363397/0001363399-07-000020-index.htm

2007-07-11 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 6992 shares at $4.67 remaining shares owned 2838871

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 parnters qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as the the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-11 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000019.txt Sec File: edgar/data/1363397/0001363399-07-000019-index.htm

2007-07-10 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 6910 shares at $4.58 remaining shares owned 2849253

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposed of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-11 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000019.txt Sec File: edgar/data/1363397/0001363399-07-000019-index.htm

2007-07-10 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 1740 shares at $4.58 remaining shares owned 2845863

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f4 these shares were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposed of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-11 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000019.txt Sec File: edgar/data/1363397/0001363399-07-000019-index.htm

2007-07-10 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 1650 shares at $4.58 remaining shares owned 2847603

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f3 these shares were sold from 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposed of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-10 by 1837 Partners L.P. SEC CIK 1363397 Form 4/a

Accession 0001363399-07-000018.txt Sec File: edgar/data/1363397/0001363399-07-000018-index.htm

2007-07-06 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 4800 shares at $4.64 remaining shares owned 2858463

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f3 these shares were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-10 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000017.txt Sec File: edgar/data/1363397/0001363399-07-000017-index.htm

2007-07-09 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 370 shares at $4.65 remaining shares owned 2856553

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f3 these shares were sold from 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd.("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rate interest in the profits of the partnerships.


Filed on 2007-07-10 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000017.txt Sec File: edgar/data/1363397/0001363399-07-000017-index.htm

2007-07-09 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 390 shares at $4.65 remaining shares owned 2856163

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f4 these shares were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd.("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rate interest in the profits of the partnerships.


Filed on 2007-07-10 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000017.txt Sec File: edgar/data/1363397/0001363399-07-000017-index.htm

2007-07-09 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 1540 shares at $4.65 remaining shares owned 2856923

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd.("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rate interest in the profits of the partnerships.


Filed on 2007-07-10 by 1837 Partners L.P. SEC CIK 1363397 Form 4/a

Accession 0001363399-07-000018.txt Sec File: edgar/data/1363397/0001363399-07-000018-index.htm

2007-07-06 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 2700 shares at $4.64 remaining shares owned 2863263

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-09 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000016.txt Sec File: edgar/data/1363397/0001363399-07-000016-index.htm

2007-07-06 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 2700 shares at $4.64 remaining shares owned 2863263

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-09 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000016.txt Sec File: edgar/data/1363397/0001363399-07-000016-index.htm

2007-07-06 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 4800 shares at $4.64 remaining shares owned 2585463

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f3 these shares were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc, disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to the securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-06 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000015.txt Sec File: edgar/data/1363397/0001363399-07-000015-index.htm

2007-07-05 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 3812 shares at $4.65 remaining shares owned 2865963

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f3 these securities were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-06 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000015.txt Sec File: edgar/data/1363397/0001363399-07-000015-index.htm

2007-07-05 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 2140 shares at $4.65 remaining shares owned 2869775

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-03 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000014.txt Sec File: edgar/data/1363397/0001363399-07-000014-index.htm

2007-07-02 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 71200 shares at $4.56 remaining shares owned 2800715

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-03 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000014.txt Sec File: edgar/data/1363397/0001363399-07-000014-index.htm

2007-07-02 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 49700 shares at $4.59 remaining shares owned 2871915

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f4 these shares were purchased for 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-07-03 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000014.txt Sec File: edgar/data/1363397/0001363399-07-000014-index.htm

2007-07-02 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 21500 shares at $4.59 remaining shares owned 2822215

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f3 these shares were purchased for 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-06-14 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000013.txt Sec File: edgar/data/1363397/0001363399-07-000013-index.htm

2007-06-13 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 6300 shares at $4.76 remaining shares owned 2871915

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f4 these shares were purchased for 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-06-14 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000013.txt Sec File: edgar/data/1363397/0001363399-07-000013-index.htm

2007-06-13 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 1800 shares at $4.73 remaining shares owned 2865615

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f3 these shares were sold from 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-06-14 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000013.txt Sec File: edgar/data/1363397/0001363399-07-000013-index.htm

2007-06-13 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 4500 shares at $4.74 remaining shares owned 2867415

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-06-04 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000012.txt Sec File: edgar/data/1363397/0001363399-07-000012-index.htm

2007-06-01 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 15800 shares at $4.67 remaining shares owned 2871915

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f4 these shares were purchased for 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb manageres llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934. as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-06-04 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000012.txt Sec File: edgar/data/1363397/0001363399-07-000012-index.htm

2007-06-01 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 75800 shares at $4.65 remaining shares owned 2796115

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb manageres llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934. as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-06-04 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000012.txt Sec File: edgar/data/1363397/0001363399-07-000012-index.htm

2007-06-01 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 60000 shares at $4.67 remaining shares owned 2856115

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f3 there shares were purchased for 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb manageres llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934. as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-16 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000011.txt Sec File: edgar/data/1363397/0001363399-07-000011-index.htm

2007-05-15 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 3000 shares at $4.51 remaining shares owned 2871915

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f2 these shares are allocated to 1837 parnters qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-14 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000010.txt Sec File: edgar/data/1363397/0001363399-07-000010-index.htm

2007-05-11 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 4970 shares at $4.4 remaining shares owned 2868915

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f2 these shares are allocated to 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed as the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-10 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000009.txt Sec File: edgar/data/1363397/0001363399-07-000009-index.htm

2007-05-09 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 23692 shares at $4.41 remaining shares owned 2840253

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-10 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000009.txt Sec File: edgar/data/1363397/0001363399-07-000009-index.htm

2007-05-09 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 23692 shares at $4.44 remaining shares owned 2863945

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f3 these shares were purchased for 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-09 by 1837 Partners L.P. SEC CIK 1363397 Form 4/a

Accession 0001363399-07-000008.txt Sec File: edgar/data/1363397/0001363399-07-000008-index.htm

2007-05-08 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 6000 shares at $4.47 remaining shares owned 2863945

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f2 these shares are allocated to 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-08 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000007.txt Sec File: edgar/data/1363397/0001363399-07-000007-index.htm

2007-05-07 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 1900 shares at $4.58 remaining shares owned 2856049

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: S Open market or private sale of securities

f2 these shares were sold from 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-08 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000007.txt Sec File: edgar/data/1363397/0001363399-07-000007-index.htm

2007-05-07 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 1900 shares at $4.58 remaining shares owned 2857945

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f3 these shares were purchased for 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-07 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000006.txt Sec File: edgar/data/1363397/0001363399-07-000006-index.htm

2007-05-03 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 16210 shares at $4.56 remaining shares owned 2857945

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f4 these shares are allocated to 1837 partners ltd.
f1 these securities are directly owned by 1837 parnters l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-07 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000006.txt Sec File: edgar/data/1363397/0001363399-07-000006-index.htm

2007-05-03 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 1694 shares at $4.35 remaining shares owned 2841735

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f4 these shares are allocated to 1837 partners ltd.
f1 these securities are directly owned by 1837 parnters l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-07 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000006.txt Sec File: edgar/data/1363397/0001363399-07-000006-index.htm

2007-05-03 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 15420 shares at $4.56 remaining shares owned 2840041

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f3 these shares are allocated to 1837 partners qp l.p.
f1 these securities are directly owned by 1837 parnters l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-07 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000006.txt Sec File: edgar/data/1363397/0001363399-07-000006-index.htm

2007-05-03 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 1610 shares at $4.35 remaining shares owned 2824621

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f3 these shares are allocated to 1837 partners qp l.p.
f1 these securities are directly owned by 1837 parnters l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-07 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000006.txt Sec File: edgar/data/1363397/0001363399-07-000006-index.htm

2007-05-03 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 68370 shares at $4.56 remaining shares owned 2823011

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f2 these shares are allocated to 1837 partners l.p.
f1 these securities are directly owned by 1837 parnters l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-07 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000006.txt Sec File: edgar/data/1363397/0001363399-07-000006-index.htm

2007-05-03 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 7140 shares at $4.35 remaining shares owned 2754641

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f2 these shares are allocated to 1837 partners l.p.
f1 these securities are directly owned by 1837 parnters l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-03 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000005.txt Sec File: edgar/data/1363397/0001363399-07-000005-index.htm

2007-05-02 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 20510 shares at $4.29 remaining shares owned 2747501

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f4 these shares are allocated to 1837 partners l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-03 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000005.txt Sec File: edgar/data/1363397/0001363399-07-000005-index.htm

2007-05-02 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 4630 shares at $4.29 remaining shares owned 2726991

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f3 these shares are allocated to 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-03 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000005.txt Sec File: edgar/data/1363397/0001363399-07-000005-index.htm

2007-05-02 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 4860 shares at $4.29 remaining shares owned 2722361

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f2 these shares are allocated to 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-05-03 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000005.txt Sec File: edgar/data/1363397/0001363399-07-000005-index.htm

2007-05-01 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 1000 shares at $4.32 remaining shares owned 2717501

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f2 these shares are allocated to 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-25 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000004.txt Sec File: edgar/data/1363397/0001363399-07-000004-index.htm

2007-04-23 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 18000 shares at $4.53 remaining shares owned 2636501

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f2 these shares are allocated to 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-25 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000004.txt Sec File: edgar/data/1363397/0001363399-07-000004-index.htm

2007-04-24 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 46500 shares at $4.64 remaining shares owned 2714901

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f3 these shares are allocated to 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-25 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000004.txt Sec File: edgar/data/1363397/0001363399-07-000004-index.htm

2007-04-24 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 1500 shares at $4.58 remaining shares owned 2668401

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f3 these shares are allocated to 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-25 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000004.txt Sec File: edgar/data/1363397/0001363399-07-000004-index.htm

2007-04-24 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 28500 shares at $4.64 remaining shares owned 2666901

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f2 these shares are allocated to 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-25 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000004.txt Sec File: edgar/data/1363397/0001363399-07-000004-index.htm

2007-04-24 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 1900 shares at $4.58 remaining shares owned 2638401

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f2 these shares are allocated to 1837 partners ltd.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-25 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000004.txt Sec File: edgar/data/1363397/0001363399-07-000004-index.htm

2007-04-24 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 1600 shares at $4.58 remaining shares owned 2716501

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f4 these shares are allocated to 1837 partners l.p.
f1 these securities are directly owned by 1837 partners l.p., 1837 partners qp l.p., and 1837 partners ltd. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-13 by 1837 Partners Qp L.P. SEC CIK 1376884 Form 4

Accession 0001363399-07-000003.txt Sec File: edgar/data/1376884/0001363399-07-000003-index.htm

2007-04-10 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 5000 shares at $4.38 remaining shares owned 2552601

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f1 these securities are directly owned by 1837 partners l.p. and 1837 partners qp l.p. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-13 by 1837 Partners Qp L.P. SEC CIK 1376884 Form 4

Accession 0001363399-07-000003.txt Sec File: edgar/data/1376884/0001363399-07-000003-index.htm

2007-04-11 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 5900 shares at $4.23 remaining shares owned 2585901

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f1 these securities are directly owned by 1837 partners l.p. and 1837 partners qp l.p. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-13 by 1837 Partners Qp L.P. SEC CIK 1376884 Form 4

Accession 0001363399-07-000003.txt Sec File: edgar/data/1376884/0001363399-07-000003-index.htm

2007-04-11 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 22600 shares at $4.23 remaining shares owned 2608501

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f1 these securities are directly owned by 1837 partners l.p. and 1837 partners qp l.p. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-13 by 1837 Partners Qp L.P. SEC CIK 1376884 Form 4

Accession 0001363399-07-000003.txt Sec File: edgar/data/1376884/0001363399-07-000003-index.htm

2007-04-12 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 7900 shares at $4.27 remaining shares owned 2618501

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f1 these securities are directly owned by 1837 partners l.p. and 1837 partners qp l.p. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-13 by 1837 Partners Qp L.P. SEC CIK 1376884 Form 4

Accession 0001363399-07-000003.txt Sec File: edgar/data/1376884/0001363399-07-000003-index.htm

2007-04-12 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 2100 shares at $4.27 remaining shares owned 2610601

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f1 these securities are directly owned by 1837 partners l.p. and 1837 partners qp l.p. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-04-13 by 1837 Partners Qp L.P. SEC CIK 1376884 Form 4

Accession 0001363399-07-000003.txt Sec File: edgar/data/1376884/0001363399-07-000003-index.htm

2007-04-10 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 27400 shares at $4.32 remaining shares owned 2580001

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f1 these securities are directly owned by 1837 partners l.p. and 1837 partners qp l.p. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers llc, may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers llc disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers llc's pro rata interest in the profits of the partnerships.


Filed on 2007-03-26 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000002.txt Sec File: edgar/data/1363397/0001363399-07-000002-index.htm

2007-03-23 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 208776 shares at $3.78 remaining shares owned 2547601

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f3 all 208,776 shares are allocated to 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p. and 1837 partners qp l.p. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers l.l.c., may be deemed to be the beneficial owner of the issuer's securities held by the parnterships. 1837 rmb managers l.l.c. disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers l.l.c.'s pro rata interest in the profits of the partnerships.


Filed on 2007-03-26 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000002.txt Sec File: edgar/data/1363397/0001363399-07-000002-index.htm

2007-03-22 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 19500 shares at $3.72 remaining shares owned 2338825

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f2 all 19,500 shares are allocated to 1837 partners qp l.p.
f1 these securities are directly owned by 1837 partners l.p. and 1837 partners qp l.p. ("partnerships"). as the general partner to the partnerships, 1837 rmb managers l.l.c., may be deemed to be the beneficial owner of the issuer's securities held by the parnterships. 1837 rmb managers l.l.c. disclaims any beneficial ownership of any of the issuer's securities reported herein for the purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers l.l.c.'s pro rata interest in the profits of the partnerships.


Filed on 2007-01-03 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000001.txt Sec File: edgar/data/1363397/0001363399-07-000001-index.htm

2006-12-29 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 302532 shares at $0 remaining shares owned 0

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb execution date 2006-12-29 exercise date 2005-05-05 exercise price 1.15 has valueitem expiration due date 2010-05-31 underlying security shares 302532 underlying security title Warrants

f1 these securities are directly owned by 1837 partners l.p. ("partnership") as the general partner to the partnership, 1837 rmb managers l.l.c. may be deemed to be the beneficial owner of the issuer's securities held by the partnership. 1837 rmb managers l.l.c. disclaims any beneficial ownership of any of the issuer's securities reported herein for purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 managers l.l.c.'s pro rata interest in the profits of the partnership.


Filed on 2007-01-03 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000001.txt Sec File: edgar/data/1363397/0001363399-07-000001-index.htm

2006-12-29 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 302533 shares at $0 remaining shares owned 0

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb execution date 2006-12-29 exercise date 2004-08-20 exercise price 1.15 has valueitem expiration due date 2009-07-30 underlying security shares 302533 underlying security title Warrants

f1 these securities are directly owned by 1837 partners l.p. ("partnership") as the general partner to the partnership, 1837 rmb managers l.l.c. may be deemed to be the beneficial owner of the issuer's securities held by the partnership. 1837 rmb managers l.l.c. disclaims any beneficial ownership of any of the issuer's securities reported herein for purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 managers l.l.c.'s pro rata interest in the profits of the partnership.


Filed on 2007-01-03 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-07-000001.txt Sec File: edgar/data/1363397/0001363399-07-000001-index.htm

2006-12-29 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc sold 100000 shares at $0 remaining shares owned 0

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb execution date 2006-12-29 exercise date 2006-04-19 exercise price 1.15 has valueitem expiration due date 2009-07-30 underlying security shares 100000 underlying security title Warrants

f1 these securities are directly owned by 1837 partners l.p. ("partnership") as the general partner to the partnership, 1837 rmb managers l.l.c. may be deemed to be the beneficial owner of the issuer's securities held by the partnership. 1837 rmb managers l.l.c. disclaims any beneficial ownership of any of the issuer's securities reported herein for purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 managers l.l.c.'s pro rata interest in the profits of the partnership.


Filed on 2006-09-29 by 1837 Partners L.P. SEC CIK 1363397 Form 4/a

Accession 0001363399-06-000003.txt Sec File: edgar/data/1363397/0001363399-06-000003-index.htm

2006-09-22 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 300000 shares at $1.5 remaining shares owned 2319325

Aspen Bio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f3 266,400 shares are allocated to 1837 partners l.p. and 33,600 are allocated to 1837 partners qp l.p.
f1 this total includes 1,614,260 shares of common stock and 705,065 warrants (rights to buy). the shares and warrants are allocated as follows: 1837 partners l.p. holds 1,580,660 shares of common stock and 705,065 warrants (rights to buy) and 1837 partners qp l.p.holds 33,600 shares of common stock.
f2 these securities are directly owned by 1837 partners l.p. and 1837 partners qp l.p. ("partnerships") as the general partner to the partnerships, 1837 rmb managers l.l.c. may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers l.l.c. disclaims any beneficial ownership of any of the issuer's securities reported herein for purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 managers l.l.c.'s pro rata interest in the profits of the partnerships.


Filed on 2006-09-26 by 1837 Partners L.P. SEC CIK 1363397 Form 4

Accession 0001363399-06-000002.txt Sec File: edgar/data/1363397/0001363399-06-000002-index.htm

2006-09-22 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc bought 300000 shares at $1.5 remaining shares owned 2319325

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb Transaction code: P Open market or private purchase of securities

f1 this total includes 1,614,260 shares of common stock and 705,065 warrants (rights to buy).
f2 these securities are directly owned by 1837 partners l.p. and 1837 partners qp l.p. ("partnerships") as the general partner to the partnerships, 1837 rmb managers l.l.c. may be deemed to be the beneficial owner of the issuer's securities held by the partnerships. 1837 rmb managers l.l.c. disclaims any beneficial ownership of any of the issuer's securities reported herein for purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 managers l.l.c.'s pro rata interest in the profits of the partnerships.


Filed on 2006-06-15 by 1837 Partners L.P. SEC CIK 1363397 Form 3/a

Accession 0001363399-06-000001.txt Sec File: edgar/data/1363397/0001363399-06-000001-index.htm

2006-05-04 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc remaining shares owned 1314260

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb

f1 these securities are directly owned by 1837 partners l.p. ("limited partnership"). as the general partner to the limited partnership, 1837 rmb managers l.l.c. may be deemed to be the beneficial owner of the issuer's securities held by the limited partnership. 1837 rmb managers l.l.c. disclaims any beneficial ownership of any of the issuer's securities reported herein for purposes of rule 16a-1 under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 managers l.l.c.'s pro rata interest in the profits of the limited partnership.


Filed on 2006-05-18 by 1837 Partners L.P. SEC CIK 1363397 Form 3

Accession 0001332905-06-000011.txt Sec File: edgar/data/1363397/0001332905-06-000011-index.htm

2006-05-04 1837 Rmb Managers Llc (CIK 1363399) through Direct

Invested in Aspenbio Pharma Inc remaining shares owned 1314260

Aspenbio Pharma Inc Aspenbio Pharma Inc Apnb

f1 these securities are directly owned by 1837 partners l.p. ("limited partnership"). as the general partner to the limited partnership, 1837 rmb managers l.l.c. may be deemed to be the beneficial owner of the issuer's securities held by the limited partnership. 1837 rmb managers l.l.c. disclaims any beneficial ownership of any of the issuer's securities reported herein for purposes of rule 16a-1(a) under the securities exchange act of 1934, as amended, or otherwise, except as to securities representing 1837 rmb managers l.l.c.'s pro rata interest in, and interest in the profits of the limited partnership.